DCs are the most efficient APCs for reactivating myelin-specific CD4+ T-cells in the CNS (Yogev et al., 2012; Mohammad et al., 2013), and they are present in cerebrospinal fluid (CSF) and CNS lesions of MS patients (Nuyts et al., 2013). Here, CD4 is linked to myeloid sarcoma.